IRIDEX (NASDAQ:IRIX) Coverage Initiated by Analysts at StockNews.com

Investment analysts at StockNews.com began coverage on shares of IRIDEX (NASDAQ:IRIX) in a research report issued on Friday. The brokerage set a “hold” rating on the medical equipment provider’s stock.

IRIDEX Stock Performance

Shares of IRIX opened at $1.52 on Friday. The stock has a 50-day simple moving average of $1.65 and a 200-day simple moving average of $1.73. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.85 and a current ratio of 1.54. The stock has a market capitalization of $25.29 million, a PE ratio of -2.27 and a beta of 0.84. IRIDEX has a 1 year low of $1.27 and a 1 year high of $3.65.

IRIDEX Company Profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.